EU Politicians: 'Bring Pharma Manufacturing Back To Europe'

EFPIA Expresses Concern About Some Proposals In Report

The pharmaceutical industry has given a muted welcome to proposals for building up the EU's resilience to medicine shortages, saying many of the ideas will not tackle the root causes of supply problems and could even serve to undermine innovation. 

Out_Of_Stock
Action is needed on many fronts to tackle drug shortages in Europe • Source: Shutterstock

The European Parliament says the coronavirus pandemic has exposed the hazards of the EU’s reliance on third countries for medicines supply and has proposed that its vulnerability to drug shortages should be addressed by offering pharmaceutical companies incentives to bring some manufacturing back to Europe.

“Priority needs to be given to boosting domestic production of essential and strategic medicines as currently 40% of medicines marketed...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography